The European Association for Cancer Research (EACR), Barcelona, Spain
13-15 May 2025
One of our most popular conferences, Defence is the Best Attack 2025 will be our fifth edition on this topic. Participants will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies, including the identification of novel targets. You will gain an improved understanding of the mechanisms of action of therapeutic interventions, and benefit from discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy. The target audience for this conference is: basic and translational scientists and clinicians, as well as both senior and young investigators that want to have a broad overview and detailed knowledge of the most recent advances in immunotherapy. Keywords: cancer research, oncology, immunotherapy, immune-oncology, molecular oncology, tumour-immune system interactions, novel therapeutic approaches, basic cancer research, clinical cancer research, treatment response biomarkers, intrinsic treatment resistance mechanisms, acquired treatment resistance mechanisms, immune checkpoints, microbioma, vaccines, immune cell therapies.
|
|